Roche's fat-burning drug shows promise for diabetes

12/14/2011 | Bloomberg

Roche Holding's experimental fat-burning drug helped lower blood glucose levels for 30 days and induce a 10% weight reduction in mice with diabetes, a study in Science Translational Medicine revealed. The drug also helped activate calorie-burning brown fats, increase energy spending and decrease liver fat, researchers said.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Director, Quality Regulatory Affairs
Cardinal Health
Chicago, IL
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC